Press release
Ophthalmic Steroid Drugs Market Driven by Eye Disease Incidence and Novel Formulations | Bausch & Lomb Inc., Alimera Sciences, Allergan, Inc., Novartis AG, GlaxoSmithKline plc
Ophthalmic Steroids Drugs Market
Ophthalmic Steroids Drugs Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With demand for effective postsurgical inflammation control, advancements in nanoparticle-based formulations, and evolving regulatory approvals, the report delivers strategic insights for stakeholders in ophthalmic care from 2025 to 2033.
In the United States, Harrow recently acquired exclusive commercial rights to clobetasol propionate ophthalmic suspension (BYQLOVI) FDA-approved in March 2024, for the relief of post-ocular surgery pain and inflammation, with launch planned for Q4 2025. Additionally, the FDA approved prednisolone acetate ophthalmic suspension (1%) in mid-2025 as a self-administered eye drop to treat steroid-responsive ocular inflammation, with rollout expected in Q3-Q4 2025
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/ophthalmic-steroids-drugs-market?ophp
Ophthalmic steroid drugs are used to reduce inflammation in eye conditions such as uveitis, post-surgical swelling, and allergic conjunctivitis. The market is driven by increasing ophthalmic disease prevalence, aging populations, and new sustained-release formulations.
Ophthalmic Steroids Drugs Market Competitors Overview:
Bausch & Lomb Inc., Alimera Sciences, Allergan, Inc., Novartis AG, GlaxoSmithKline plc, Genentech, Inc., Pfizer Inc., Bayer AG, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. Shanghai Pharmaceutical Group Co., Ltd., China Res
Important Industry Updates:
On June 11, 2020, Novartis announced that the US Food and Drug Administration (FDA) had approved a label update for Beovu® (brolucizumab) to include additional safety information regarding retinal vasculitis and retinal vascular occlusion.
Methodology and Scope
The Ophthalmic Steroids Drugs Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/ophthalmic-steroids-drugs-market?ophp
Ophthalmic Steroids Drugs Market Segments Overview:
By Disease (Retinal Disorders, Eye Allergy, Uveitis, Others), By Dosage Form (Eye Drops, Eye Solutions, Ointments), By Distribution Channel (Hospital pharmacies, Online pharmacies, Clinics)
Regional Overview for Ophthalmic Steroids Drugs Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=ophthalmic-steroids-drugs-market?ophp
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the Ophthalmic Steroids Drugs market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Ophthalmic Steroids Drugs market?
Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ophthalmic Steroid Drugs Market Driven by Eye Disease Incidence and Novel Formulations | Bausch & Lomb Inc., Alimera Sciences, Allergan, Inc., Novartis AG, GlaxoSmithKline plc here
News-ID: 4140667 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Morquio Syndrome Therapy Market Grows with Enzyme Replacement Innovations and Or …
The global Morquio Syndrome Therapy Market size was valued US$ 1.5 Mn by 2032 in 2024, and is estimated to reach 5.4 million by 2033, growing at a CAGR of 11.62% during the forecast period (2025-2033).
Morquio Syndrome Therapy Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With increasing attention to rare disease treatments,…
Intratumoral Cancer Therapies Market Boosted by Immunotherapy Advances and Local …
The global Intratumoral Cancer Therapies Market size was valued USD 255.27 billion in 2024, and is estimated to reach USD 659.43 billion by 2033, growing at a CAGR of 10.62% during the forecast period (2025-2033).
Intratumoral Cancer Therapies Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With increasing interest in localized immunotherapeutics, clinical trial…
Generalized Myasthenia Gravis Market Driven by Rare Disease Awareness and Biolog …
Generalized Myasthenia Gravis Treatment Market size reached US$ 3.78 billion in 2024 and is expected to reach US$ 15.57 billion by 2033, growing at a CAGR of 17.1% during the forecast period 2025-2033.
Generalized Myasthenia Gravis Treatment Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With rising autoimmune prevalence, novel biologics, and growing adoption…
Epoxy Coating Market Size & Share 2025: Explore Emerging Technologies and Growth …
A Report by DataM Intelligence estimates the Global Epoxy Coating market to grow at a high CAGR during the forecast period 2024-2031.reached at a CAGR during the forecast period 2024-2031. The Epoxy Coating Market is experiencing growth during 2024-2031 due to increasing demand for durable, corrosion-resistant, and chemically stable coatings across industries such as construction, automotive, marine, and oil & gas. Rising infrastructure development, expanding industrial activities, and the growing…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
